- Home
- KRNT vs KURA Comparison
KRNT vs KURA Comparison
Compare KRNT & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRNT | KURA |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.1M | 830.1M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRNT | KURA |
|---|---|---|
| Price | $15.82 | $8.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $19.75 | ★ $26.88 |
| AVG Volume (30 Days) | 405.9K | ★ 1.4M |
| Earning Date | 02-11-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,200,000.00 | $104,029,000.00 |
| Revenue This Year | $4.28 | $88.72 |
| Revenue Next Year | $8.37 | $68.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $11.93 | $5.41 |
| 52 Week High | $30.03 | $12.49 |
Technical Indicators
Market Signals| Indicator | KRNT | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 64.21 | 44.59 |
| Support Level | $14.23 | $7.50 |
| Resistance Level | $17.96 | $8.08 |
| Average True Range (ATR) | 0.73 | 0.34 |
| MACD | 0.35 | 0.07 |
| Stochastic Oscillator | 67.74 | 68.99 |
Price Performance
Historical ComparisonAbout KRNT Kornit Digital Ltd.
Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.